Meropenem
Especificaciones
96036-03-2Número CAS
641-424-1Número CE
(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acidNombre IUPAC
C17H25N3O5SFórmula química
383.5 g/molPeso molecular
meropenem; 96036-03-2; Merrem; Meropenem anhydrous; Meropenemum; Antibiotic SM 7338; MERONEM; Merrem I.V.; MEPM; SM-7338; Meropenem, anhydrous; ICI-194660; (4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; DTXSID7045526; YOP6PX0BAO; CHEBI:43968; Merrem IV; (4r,5s,6s)-3-{[(3s,5s)-5-(Dimethylcarbamoyl)pyrrolidin-3-Yl]sulfanyl}-6-[(1r)-1-Hydroxyethyl]-4-Methyl-7-Oxo-1-Azabicyclo[3.2.0]hept-2-Ene-2-Carboxylic Acid; Meropenem (as trihydrate); ICI 194,660; DTXCID5025526; NSC-759621; (4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(S*,5S*),4-alpha,5-beta,6-beta(R*)))-; VABOMERE COMPONENT MEROPENEM; (4R,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)sulfanyl)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; (4R,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; (4R,5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)sulfanyl-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; RefChem:6003; 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, trihydrate, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-; Meropenem and Sodium Chloride; J01DH02; SM7338; MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER; (4R,5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-1-ium-3-yl)sulfanyl-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate; 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-; FV9J3JU8B1; Meropenem [INN]; Meropenemum [INN-Latin]; (4R,5S,6S)-3-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; Meropenem (INN); ICI 194660; SM 7338; MEROPENEM SODIUM CARBONATE; NCGC00016962-01; Meropenem (trihydrate); (4R,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; Meropen; SM 7338 trihydrate; Meronem (TN); CAS-96036-03-2; Merrem I.V. (TN); SR-01000762894; UNII-YOP6PX0BAO; HSDB 8019; M2279; BRN 6940582; Meropenem (closed form); MEROPENEM [MI]; Prestwick0_001106; Prestwick1_001106; Prestwick2_001106; Prestwick3_001106; CHEMBL127; Epitope ID:195064; MEROPENEM [WHO-DD]; SCHEMBL34442; BSPBio_001212; MLS001401437; BIDD:GT0851; SPBio_003086; BPBio1_001334; GTPL10829; GLXC-15451; HMS1571M14; HMS2051G08; HMS2090C05; HMS2098M14; HMS3715M14; 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-; Tox21_110715; Tox21_113794; BDBM50129062; EBC-26879; AKOS015920140; Tox21_110715_1; AM32026; CCG-100850; CS-1865; DB00760; KS-5224; NC00100; NCGC00179259-01; NCGC00179259-06; NCGC00179259-15; NCGC00179259-17; NCGC00253670-01; NCGC00262579-02; (6S)-2-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-1beta-methyl-2,3-didehydro-1-carbapenam-3-carboxylic acid; HY-13678; SMR000469184; AB00514051; NS00004619; D08185; M-2780; M05727; AB00514051-02; AB00698370-05; EN300-1721646; Q421670; SR-01000762894-3; SR-01000762894-4; BRD-K01612348-001-11-4; Meropenem trihydrate, Antibiotic for Culture Media Use Only; (1R,5S,6S)-2-[(3S,5S)-5-(dimethylaminocarbonyl)pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid; (1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-YLTHIO]-6-[(R)-1-HYDROXYETHYL]-1-METHYLCARBAPEN-2-EM-3-CARBOXYLIC ACID; (4R,5S,6S)-3-(((3S,5S)-5-(DIMETHYLCARBAMOYL)-3-PYRROLIDINYL)THIO)-6-((1R)-1-HYDROXYETHYL)-4-METHYL-7-OXO-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID; (4R,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid; (4R,5S,6S)-3-[[(3S,5S)-5-(dimethylaminocarbonyl)-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acidSinónimos
Productos que contienen Meropenem
MEROPENEM SUN 500 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGMEROPENEM SUN 1g POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGMEROPENEM HIKMA 2 G POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓNAresonem 1gBironem 1gBironem 500Carmero 0,5 gCarmero 1gEfnem 1gEmerop 0,5gEmerop 1gMeremed 1g
Página 1 de 13
Empresas que venden Meropenem
CT
Công Ty Cổ Phần Dược Phẩm Tv.Pharm Viet NamCT
Công ty TNHH Phil Inter PharmaViet NamCT
Công ty TNHH Dược phẩm GlomedViet NamCT
Công ty TNHH Dược phẩm Shinpoong DaewooViet NamPágina 1 de 9